GAGE L PATRICK Insider Trading $TTPH TETRAPHASE PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GAGE L PATRICK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GAGE L PATRICK. GAGE L PATRICK is Director in CYTOKINETICS INC ($CYTK) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH).

Over the past year GAGE L PATRICK has been an insider in 1 company. The total value of shares held by GAGE L PATRICK in this company amounts to $322,089.

GAGE L PATRICK Director
CYTOKINETICS INC
Director
TETRAPHASE PHARMACEUTICALS INC
$ 322089 The total value of shares held by GAGE L PATRICK
Insider Rank

GAGE L PATRICK ranks 20,903 out of 350,000 insiders. Go to Insider Ranking to see more.

GAGE L PATRICK in TETRAPHASE PHARMACEUTICALS INC

Trading Symbol: TTPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GAGE L PATRICK: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 29 2020
$TTPH Market Capitalization: $155.73M
$TTPH Previous Close: $4.18

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 3x
Sell: 2x
Shares Bought: 14,880
Shares Sold: 2,135
Share Difference: +12,745
Value Difference: -$107,396

Latest Insider Trading Transactions of GAGE L PATRICK in TETRAPHASE PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000002
Value of Sales ($)0000000

Sentiment: All, CYTK, TTPH

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 29 2020TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorSellU0.0019100191 to 0 (-100.00 %)
Jul 29 2020TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorSellU0.001,944001.9 K to 0 (-100.00 %)
Jun 11 2019TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorOption ExerciseA0.7716,50012,70516,500
Jun 01 2018TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorOption ExerciseA3.6812,50046,00012,500
Dec 04 2017TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorBuyP6.453,88025,02638,88035 K to 38.9 K (+11.09 %)
Jun 01 2017TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorOption ExerciseA6.8912,50086,12512,500
Mar 16 2017TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorBuyP7.471,0007,4703,8252.8 K to 3.8 K (+35.40 %)
Mar 16 2017TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorBuyP7.4910,00074,90035,00025 K to 35 K (+40.00 %)
Jun 10 2016TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorOption ExerciseA4.2710,00042,70010,000
Oct 06 2015TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorOption ExerciseM2.0320,00040,60034,544
Oct 06 2015TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorBuyM2.0320,00040,60025,0005 K to 25 K (+400.00 %)
Aug 14 2015TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorOption ExerciseM7.0715,000106,0505,000
Aug 14 2015TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorSellS45.0015,000675,0005,00020 K to 5 K (-75.00 %)
Aug 14 2015TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorBuyM7.0715,000106,05020,0005 K to 20 K (+300.00 %)
Jun 11 2015TTPHTETRAPHASE PHARMAC ...GAGE L PATRICKDirectorOption ExerciseA42.2610,000422,60010,000

Page:   1